{"id":7920,"date":"2026-01-23T10:32:55","date_gmt":"2026-01-23T09:32:55","guid":{"rendered":"https:\/\/goba.eu\/erecyn-projekt-trajnostna-proizvodnja-standardiziranih-prehranskih-dopolnil-iz-glive-hericium\/"},"modified":"2026-03-02T14:40:56","modified_gmt":"2026-03-02T13:40:56","slug":"erecyn-project-sustainable-production-of-standardized-dietary-supplements-from-hericium","status":"publish","type":"post","link":"https:\/\/goba.eu\/en\/erecyn-project-sustainable-production-of-standardized-dietary-supplements-from-hericium\/","title":{"rendered":"eRECYn Project \u2013 Sustainable Production of Standardized Dietary Supplements from Hericium"},"content":{"rendered":"
\n
\"\"\u00a0 \u00a0 \u00a0\u00a0 \"\" \"\"<\/figure>\n
<\/figure>\n<\/figure>\n

<\/h2>\n

eRECYn Project \u2013 Sustainable Production of Standardized Dietary Supplements from Hericium<\/h2>\n

(01.11.2022 \u2013 30.11.2024)<\/p>\n

 <\/p>\n

<\/div>\n
\n

The aim of the project is to develop a dietary supplement from the medicinal fungus Hericium erinaceus in an innovative formulation that will be the first in the world to feature a standardized and labeled content of the main neuroprotective compound, erinacine A. The final product will be developed and marketed both as a raw material and as a finished product under the GOBA\u00ae brand. This supplement will be a high-quality product made from 100% biologically certified ingredients.<\/p>\n

The primary goal of the project is to create a completely new product representing a significant innovation in the natural dietary supplement market. Through a new, innovative process, fully optimized within the research and development activities of the project, we will fully utilize the bioactive compounds present in the extraction residues, while simultaneously minimizing waste. Moreover, the production process itself will be optimized to achieve exceptional energy efficiency. Instead of relying solely on electrical energy, waste heat from existing production processes will be utilized.<\/p>\n

These innovative production approaches will significantly contribute to the transition toward a circular economy, including mitigation of climate change, and will achieve a high level of technological neutrality. As part of the research and development project, a series of R&D activities will be conducted to fully optimize the production process. Entirely new technological procedures will be implemented to enable efficient use of extraction residues from existing production as raw materials for obtaining bioactive extracts. These procedures are not yet established or integrated into standard industrial processes for dietary supplements based on medicinal mushrooms, representing a global innovation in this field.<\/p>\n

The project will allow the development of a completely new product, requiring the optimization of production processes at laboratory, pilot, and industrial scales. The project is carried out in partnership between MycoMedica d.o.o. and PharmaHemp d.o.o.<\/p>\n<\/div>\n

<\/div>\n
\"\" \u00a0\"\"<\/div>\n
<\/div>\n

Through a new, innovative process, which will be fully optimized within the research and development activities of the project, we will maximize the utilization of bioactive compounds abundantly present in the extraction residues, while simultaneously reducing waste. At the same time, the production process itself will be optimized to achieve exceptional energy efficiency, as waste heat from existing production processes will be used instead of electrical energy. These innovative production approaches will significantly contribute to the transition toward a circular economy, including climate change mitigation, and will achieve a high level of technological neutrality.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

Within the project, a series of R&D activities will be conducted to fully optimize the production process. Entirely new technological procedures will be implemented to enable the efficient use of extraction residues from existing production as raw materials for obtaining bioactive extracts. These processes are not yet established in the industrial production of dietary supplements from medicinal mushrooms and have not been integrated into standard processing procedures, representing a global innovation in this field. The project will enable the development of a completely new product, for which production processes will need to be optimized at laboratory, pilot, and industrial scales.<\/p>\n

The total project budget amounts to EUR 539,164, with co-funding of EUR 299,981.<\/p>\n

\u00bbThe investment is part of the measures included in the Slovenian National Recovery and Resilience Plan (NRRP), financed by the European Union\u2019s Recovery and Resilience Facility.\u00ab<\/strong>\"\"<\/p>\n

Reference:<\/strong> Official website of the Slovenian National Recovery and Resilience Plan (NRRP)\u00a0 – \u00a0noo.gov.si<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Within the project, we will develop a dietary supplement from the medicinal fungus Hericium erinaceus in an innovative formulation that will be the first in the world to feature a standardized and labeled content of the main neuroprotective compound, erinacine A. The final product will be developed and marketed both as a raw material for dietary supplements and as a finished product. It will be a high-quality dietary supplement made from 100% certified organic ingredients. The primary goal of the project is to create a completely new product, representing a significant innovation in the natural dietary supplement market.<\/p>\n","protected":false},"author":3,"featured_media":6744,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1114],"tags":[1175,866,1174,1128,1176],"class_list":["post-7920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-and-development-projects","tag-bioactive-compounds","tag-hericium-erinaceus","tag-lions-mane","tag-medicinal-mushrooms","tag-standardized-content"],"acf":[],"_links":{"self":[{"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/posts\/7920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/comments?post=7920"}],"version-history":[{"count":2,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/posts\/7920\/revisions"}],"predecessor-version":[{"id":8318,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/posts\/7920\/revisions\/8318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/media\/6744"}],"wp:attachment":[{"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/media?parent=7920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/categories?post=7920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/goba.eu\/en\/wp-json\/wp\/v2\/tags?post=7920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}